Aleafia Health

Aleafia Health Provides Update Regarding Product Shipment, The ...

AH Profile

  • Sector: Process Industries
  • Industry: Agricultural Commodities/Milling
  • Employees: 173

Aleafia Health, Inc. engages in the provision of healthcare services, which focuses on medical cannabis healthcare solutions. It operates medical cannabis care through medical cannabis clinics, processing and distribution facility, and innovative research. Its brands include Emblem and Symbl. The company was founded on February 02, 2007 and is headquartered in Concord, Canada.

Recent News

Aleafia Health Subsidiary Secures Regulatory Approvals for Cannabis Sales in Germany

 — Aleafia Health Inc.’s (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) indirect subsidiary, Aleafia Health Germany GmbH (“Aleafia Germany”) will commence distributing medical cannabis products to German pharmacies following regulatory approvals. Aleafia Germany has now received a controlled drug licence from the Federal Institute for Drugs and Medical Devices and a European UnionContinue reading “Aleafia Health Subsidiary Secures Regulatory Approvals for Cannabis Sales in Germany”

Aleafia Health Announces Appointment of Pharmaceutical Executive Tricia Symmes as Chief Commercial Officer

TORONTO, Aug. 21, 2020 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) today announced the appointment of Tricia Symmes as the Company’s Chief Commercial Officer, effective August 27, 2020. Symmes brings over 20 years of experience as a senior executive in the pharmaceutical, consumer packaged goods, and cannabis industries.Continue reading “Aleafia Health Announces Appointment of Pharmaceutical Executive Tricia Symmes as Chief Commercial Officer”

Aleafia Health Announces Second Quarter 2020 Results

“Our significant increase in medical cannabis sales and patient growth, coupled with much needed Cannabis 2.0 formats and dried flower products will see us continue to capture market in both the medical and adult-use markets.” CEO Geoffrey Benic Highlights $57.0M cash, cash equivalents and freely tradeable marketable securities $3.0 million positive adjusted EBITDA 44% increaseContinue reading “Aleafia Health Announces Second Quarter 2020 Results”

Loading…

Something went wrong. Please refresh the page and/or try again.